A randomized, open-label, multiple dosing, three treatment, three period, two sequence clinical trial to investigate the pharmacokinetic/pharmacodynamic drug-drug interaction of evogliptin 5 mg and glimepiride 4 mg after oral administration in healthy male subjects
No linked publications found in PubMed
Inclusion Criteria: * Healthy Male Volunteers (Age: 19\~45years) * 55\<Body Weight\<90, 18\<BMI\<27 * FPG: 70-125 mg/dL Exclusion Criteria: * galactose intolerance, Lapp lactase deficiency, glucose-galactose malabsorption * Clinically significant Medical History * Allergy or Drug Hypersensitivity * AST(SGOT), ALT(SGPT) \> Upper Normal Range\*1.5, eGFR\<80 mL/min * Drink during clinical trial period * Smoking during clinical trial period * Grapefruit/Caffeine intake during clinical trial period * No Contraception